Fat Prophets Global Contrarian Fund Launches $8.45 Million Rights Issue with Partial Underwriting

Rights Issue Targets Market Relevance and Liquidity

Fat Prophets Global Contrarian Fund (ASX:FPC) is set to raise approximately $8.45 million through a non-renounceable pro-rata rights issue, offering one new share for every five held at a price capped at $1.50 or the five-day volume weighted average price (VWAP) up to the closing date on 2 June 2026. Alongside each new share, investors receive one rights option exercisable at $1.80 by June 2027.

This capital raise aims to increase the fund’s asset base, which the board believes will enhance trading liquidity and market relevance, potentially attracting broker and research coverage. The company’s largest shareholder and Chief Investment Officer Angus Geddes has committed to fully subscribe, contributing approximately $870,000 to the raise.

Partial Underwriting and Director Participation Signal Confidence

The rights issue is partly underwritten to the tune of $1 million by Nightingale Partners Pty Limited, providing some cushion against undersubscription. However, the bulk of the raise depends on shareholder uptake, with the directors reserving discretion to scale back or allocate shortfall shares. Eligibility is limited to shareholders with registered addresses in Australia and New Zealand, excluding offshore holders to avoid regulatory complexities.

Directors Michael Gallagher and Katrina Vanstone also plan to participate pro rata, underscoring management’s confidence in the fund’s contrarian investment thesis, which has recently delivered strong performance driven by Japanese banks, precious metals, and Chinese technology stocks.

Capital Deployment Aligned with Contrarian Strategy

Proceeds from the rights issue will be invested following FPC’s concentrated, contrarian active approach that blends top-down macroeconomic analysis with bottom-up company fundamentals and technical analysis to time market inflection points. The fund’s recent surge to a $9.3 million profit in the half-year ended December 2025, driven by global equity positions, highlights the potential of this strategy.

Increasing the fund’s size is also expected to reduce the fixed expense ratio, benefiting all shareholders by spreading costs over a larger asset base. This follows recent capital management moves including a nearly $1 million share purchase plan and a year-long on-market buy-back announced earlier in May 2026, reflecting a dynamic approach to balancing liquidity and shareholder value.

Shareholder Impact and Control Considerations

If fully subscribed, the rights issue will increase shares on issue by approximately 5.6 million to nearly 33.8 million. Shareholders who take up their full entitlement will maintain their proportional ownership, while those who do not risk dilution. The fund’s largest shareholder, HSBC Custody Nominees, currently holds 9.23% and could see its stake rise to 10.87% if it fully participates and others do not.

The company explicitly excludes related parties from applying for additional shares beyond their entitlement, and directors have capped any single shareholder’s post-issue holding below 20% to prevent control shifts. The rights issue shares will rank equally with existing shares and are expected to be quoted on ASX around 11 June 2026.

Shareholders must act by 2 June 2026 to participate, with payment via BPAY only, and no rights trading allowed. The offer booklet emphasises the speculative nature of the investment and encourages shareholders to seek professional advice.

This capital raise follows a series of recent transactions, including the $950K share purchase plan closed in September 2025 and the year-long on-market buy-back launched in May 2026, reflecting an active capital management phase for FPC.